![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanom... Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. Show more
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on June 14, 2024, the Compensation Committee of its...
Maetzold selected as a winner of Ernst & Young’s prestigious annual awards among 48 visionary finalists in the Gulf South region, encompassing Central and South Texas, Louisiana and...
Castle to present a second poster on its DecisionDx®-UM test sharing data from an ongoing prospective, multi-center study of patients with uveal melanoma (UM) led by the Collaborative Ocular...
In the study, patients with DecisionDx-SCC Class 2B test results, predicted to have the highest risk of metastasis by the test, who were treated with adjuvant radiation therapy (ART) had 50...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.34 | -10.0775193798 | 23.22 | 23.5613 | 20.76 | 252117 | 22.66305753 | CS |
4 | -3.61 | -14.7407104941 | 24.49 | 24.95 | 20.76 | 232247 | 23.20431322 | CS |
12 | -0.49 | -2.29293401965 | 21.37 | 25.91 | 18.5 | 229361 | 22.86400111 | CS |
26 | -0.08 | -0.381679389313 | 20.96 | 25.91 | 17.42 | 240545 | 22.1340556 | CS |
52 | 7.83 | 60 | 13.05 | 25.91 | 12.07 | 331525 | 19.16734775 | CS |
156 | -52.724 | -71.631976523 | 73.604 | 78.92 | 9.2601 | 279836 | 26.93866275 | CS |
260 | 0.88 | 4.4 | 20 | 107.69 | 9.2601 | 252052 | 34.28329304 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions